These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2436961)

  • 1. Functional nature of glomerular injury in progressive diabetic glomerulopathy.
    Tomlanovich S; Deen WM; Jones HW; Schwartz HC; Myers BD
    Diabetes; 1987 May; 36(5):556-65. PubMed ID: 2436961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nature of the glomerular capillary injury in human membranous glomerulopathy.
    Shemesh O; Ross JC; Deen WM; Grant GW; Myers BD
    J Clin Invest; 1986 Mar; 77(3):868-77. PubMed ID: 2419362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Charge selectivity of proteinuria in diabetic glomerulopathy.
    Nakamura Y; Myers BD
    Diabetes; 1988 Sep; 37(9):1202-11. PubMed ID: 3410164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of proteinuria in diabetic nephropathy. II. A study of the size-selective glomerular filtration barrier.
    Friedman S; Jones HW; Golbetz HV; Lee JA; Little HL; Myers BD
    Diabetes; 1983 May; 32 Suppl 2():40-6. PubMed ID: 6086024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerular function in advanced human diabetic nephropathy.
    Winetz JA; Golbetz HV; Spencer RJ; Lee JA; Myers BD
    Kidney Int; 1982 May; 21(5):750-6. PubMed ID: 6180214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of exercise on glomerular passage of macromolecules in patients with diabetic nephropathy and in healthy subjects.
    Ala-Houhala I
    Scand J Clin Lab Invest; 1990 Feb; 50(1):27-33. PubMed ID: 1690442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinuria and functional characteristics of the glomerular barrier in diabetic nephropathy.
    Carrie BJ; Myers BD
    Kidney Int; 1980 May; 17(5):669-76. PubMed ID: 6157049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy.
    Morelli E; Loon N; Meyer T; Peters W; Myers BD
    Diabetes; 1990 Jan; 39(1):76-82. PubMed ID: 1698674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the angiotensin II antagonist valsartan on blood pressure, proteinuria, and renal hemodynamics in patients with chronic renal failure and hypertension.
    Plum J; Bünten B; Németh R; Grabensee B
    J Am Soc Nephrol; 1998 Dec; 9(12):2223-34. PubMed ID: 9848776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of the antiproteinuric effect of indomethacin in nephrotic humans.
    Golbetz H; Black V; Shemesh O; Myers BD
    Am J Physiol; 1989 Jan; 256(1 Pt 2):F44-51. PubMed ID: 2463770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of proteinuria in diabetic glomerular disease.
    Myers BD
    J Hypertens Suppl; 1990 Mar; 8(1):S41-6. PubMed ID: 2332816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of overt nephropathy in non-insulin-dependent diabetes.
    Myers BD; Nelson RG; Tan M; Beck GJ; Bennett PH; Knowler WC; Blouch K; Mitch WE
    Kidney Int; 1995 Jun; 47(6):1781-9. PubMed ID: 7543961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of proteinuria in diabetic nephropathy: a study of glomerular barrier function.
    Myers BD; Winetz JA; Chui F; Michaels AS
    Kidney Int; 1982 Apr; 21(4):633-41. PubMed ID: 6178872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade.
    Ruggenenti P; Mosconi L; Sangalli F; Casiraghi F; Gambara V; Remuzzi G; Remuzzi A
    Kidney Int; 1999 Mar; 55(3):984-94. PubMed ID: 10027935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular capillary wall function in human lupus nephritis.
    Friedman S; Strober S; Field EH; Silverman E; Myers BD
    Am J Physiol; 1984 May; 246(5 Pt 2):F580-91. PubMed ID: 6720964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of atrial natriuretic peptide on renal and vascular permeability in diabetes mellitus.
    Zietse R; Derkx FH; Weimar W; Schalekamp MA
    J Am Soc Nephrol; 1995 Jun; 5(12):2057-66. PubMed ID: 7579054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular size-selectivity and microalbuminuria in early diabetic glomerular disease.
    Scandling JD; Myers BD
    Kidney Int; 1992 Apr; 41(4):840-6. PubMed ID: 1381005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular response to hyperglycemia in human diabetic nephropathy.
    Remuzzi A; Viberti G; Ruggenenti P; Battaglia C; Pagni R; Remuzzi G
    Am J Physiol; 1990 Oct; 259(4 Pt 2):F545-52. PubMed ID: 2221091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Converting enzyme inhibition and glomerular size selectivity in diabetic nephropathy.
    Meyer TW; Morelli E; Loon N; Peters W; Myers BD
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S64-8. PubMed ID: 16989068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of colloid volume expansion on glomerular barrier size-selectivity in humans.
    Shemesh O; Deen WM; Brenner BM; McNeely E; Myers BD
    Kidney Int; 1986 Apr; 29(4):916-23. PubMed ID: 3712975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.